{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 applies additional rebate requirements to generic drugs under Section 1927(c)(3) of the Social Security Act. The rebate amount for non-single source or innovator multiple source drugs is increased in a similar manner to single source or innovator multiple source drugs, with some exceptions. The Medicaid Generic Drug Price Fairness Act of 2015 applies increased rebate requirements to innovator multiple source drugs under certain provisions, with adjustments to references and special rules for application. The Medicaid Generic Drug Price Fairness Act of 2015 applies increased rebate requirements to innovator multiple source drugs with adjustments to references and special rules for application, including changes to pricing calculations and references to specific dates. The Medicaid Generic Drug Price Fairness Act of 2015 applies increased rebate requirements to innovator multiple source drugs with adjustments to references and special rules for application, including changes to pricing calculations and references to specific dates. Specifically, references to single source drugs or innovator multiple source drugs are modified to apply to drugs falling under clause (i) and special rules are established for noninnovator multiple source drugs sold after a certain date. The Medicaid Generic Drug Price Fairness Act of 2015 applies increased rebate requirements to innovator multiple source drugs with adjustments to references and special rules for application. The amendments made by subsection (a) shall apply to rebate periods beginning after December 31, 2014."
}